Mainz Biomed BV
NASDAQ:MYNZ

Watchlist Manager
Mainz Biomed BV Logo
Mainz Biomed BV
NASDAQ:MYNZ
Watchlist
Price: 1.05 USD -4.55% Market Closed
Market Cap: 5.7m USD

Mainz Biomed BV
Investor Relations

Mainz Biomed BV operates as a biotechnology company. The company is headquartered in Mainz, Hessen. The company went IPO on 2021-11-04. The firm operates under one segment, namely genetic diagnostic testing services. Its portfolio consists of various products and product candidates, such as ColoAlert, a colorectal cancer (CRC) screening stool-based DNA (deoxyribonucleic acid) test; PancAlert, a stool-based screening test for the detection of pancreatic cancer; GenoStrip, a platform technology to detect pathogens in environments on a molecular genetic basis. The firm competes with Exact Sciences, Epigenomics AG, Novigenix SA, GRAIL, Inc. and Agena Biosciences Inc.

Show more
Loading
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare
No Earnings Calls Available

Management

Mr. Guido Baechler
CEO & Executive Director
No Bio Available
Mr. William J. Caragol C.P.A.
Chief Financial Officer
No Bio Available
Dr. Christopher Von Torne P.M.P., Ph.D.
Chief Operating Officer
No Bio Available
Dr. Frank Krieg-Schneider
Chief Technology Officer
No Bio Available
Dr. Moritz Eidens Ph.D.
Chief Science Officer & Executive Director
No Bio Available
Stefan Erlach
Head of Human Resources
No Bio Available
Mr. Philipp Freese
Chief Business Officer
No Bio Available

Contacts

Address
HESSEN
MAINZ
Robert Koch Strasse 50
Contacts
+4961315542860.0
www.mainzbiomed.com